Carolina Wealth Makes a Big $6 Million Bet on Novo Nordisk (NYSE: NVO)

08.10.25 20:40 Uhr

Werte in diesem Artikel
Indizes

10.210,8 PKT -98,3 PKT -0,95%

PKT PKT

1.639,1 PKT 23,0 PKT 1,42%

1.302,3 PKT 14,9 PKT 1,16%

2.397,4 PKT -11,8 PKT -0,49%

4.777,9 PKT -13,6 PKT -0,28%

On October 07, 2025, Carolina Wealth Advisors, LLC disclosed a buy of Novo Nordisk A/S (NYSE: NVO) shares, an estimated $6.01 million trade based on the average price for Q3 2025.According to a U.S. Securities and Exchange Commission (SEC) filing dated October 07, 2025, Carolina Wealth Advisors, LLC increased its stake in Novo Nordisk, adding 102,629 shares during the third quarter. The estimated trade size was $6.01 million, calculated using the average closing price for the period from July 1 through September 30, 2025. The updated holding stands at 116,973 shares.This transaction was a buy, raising Novo Nordisk A/S to 2.8% of the fund’s 13F reportable AUM as of Q3 2025.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Quelle: MotleyFool

Nachrichten zu Novo Nordisk

Wer­bung

Analysen zu Novo Nordisk

DatumRatingAnalyst
06.10.2025Novo Nordisk NeutralUBS AG
06.10.2025Novo Nordisk OverweightJP Morgan Chase & Co.
03.10.2025Novo Nordisk NeutralUBS AG
01.10.2025Novo Nordisk BuyGoldman Sachs Group Inc.
30.09.2025Novo Nordisk OverweightJP Morgan Chase & Co.
DatumRatingAnalyst
06.10.2025Novo Nordisk OverweightJP Morgan Chase & Co.
01.10.2025Novo Nordisk BuyGoldman Sachs Group Inc.
30.09.2025Novo Nordisk OverweightJP Morgan Chase & Co.
19.09.2025Novo Nordisk BuyDeutsche Bank AG
18.09.2025Novo Nordisk BuyDeutsche Bank AG
DatumRatingAnalyst
06.10.2025Novo Nordisk NeutralUBS AG
03.10.2025Novo Nordisk NeutralUBS AG
23.09.2025Novo Nordisk NeutralUBS AG
18.09.2025Novo Nordisk NeutralUBS AG
16.09.2025Novo Nordisk NeutralUBS AG
DatumRatingAnalyst
06.08.2025Novo Nordisk UnderperformJefferies & Company Inc.
23.06.2025Novo Nordisk UnderperformJefferies & Company Inc.
07.05.2025Novo Nordisk UnderperformJefferies & Company Inc.
17.04.2025Novo Nordisk UnderperformJefferies & Company Inc.
03.04.2025Novo Nordisk UnderperformJefferies & Company Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Novo Nordisk nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen